City of Hope National Medical Center has expanded into the South Bay by opening a new cancer center in Torrance.
The Duarte-based hospital on Aug. 27 celebrated the grand opening of its City of Hope/South Bay center at 5215 Torrance Blvd. It occupies two floors of a new $80 million ambulatory health care clinic owned by Providence Little Company of Mary Medical Centers.
“City of Hope brings new, research-driven treatment options to the South Bay,” said Dr. Harlan Levine, its president of strategy and business ventures, in a statement. “We want to ensure patients have the premier care they deserve and still be close to home.”
The 25,000-square-foot cancer center opened two weeks ago with services in surgical, radiation and medical oncology, with 20 exam rooms and infusion areas for chemotherapy patients.
The collaboration with Providence Little Company of Mary Medical Center in Torrance also grants its patients access to the latest City of Hope cancer diagnostics, treatments and clinical trials. City of Hope has now expanded to 30 locations across Southern California.
“The opening of the City of Hope cancer center signifies a pivotal development in health care services for our South Bay communities as our two organizations work to improve patient outcomes,” said Garry Olney, interim chief executive for the Providence hospital, said in a statement.
Health business reporter Dana Bartholomew can be reached at firstname.lastname@example.org. Follow him on Twitter @_DanaBart.
For reprint and licensing requests for this article, CLICK HERE.
Stories You May Also Be Interested In
- City of Hope Expands With South Bay Clinic
- Developers Expand Medical Complex Near DTLA
- City of Hope Expands Oncology Radiation Services Across SoCal
- City of Hope to Open First Cancer Center in OC for $14M
- City of Hope Taps Annette Walker to Develop $200M Cancer Center in OC
- Cedars-Sinai to Deliver Primary Care Services to Santa Monica
- City of Hope Wins $13 Million Grant to Fight Aggressive Brain Cancer
- City of Hope Receives $3.7M to Conduct Stem Cell Research on Brain Cancer